Ipca Laboratories gets VAI classification for Piparia manufacturing facility

24 Aug 2023 Evaluate

Ipca Laboratories’ Piparia (Silvassa) formulations manufacturing facility has received Voluntary Action Indicated (VAI) classification from U.S. Food and Drug Administration (USFDA). Based on this inspection, this facility is considered to be in a minimally acceptable state of compliance with regards to current good manufacturing practice (CGMP). 
USFDA had conducted inspection at the said manufacturing facility from April 18, 2023 to April 26, 2023, which inspection resulted into 3 observations under USFDA Form 483. 

Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations.

Ipca Laboratories Share Price

1289.55 -47.90 (-3.58%)
07-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1515.15
Dr. Reddys Lab 6277.10
Cipla 1388.00
Zydus Lifesciences 980.65
Lupin 1610.55
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.